Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer

Autor: Eymard, J-C *, Priou, F., Zannetti, A., Ravaud, A., Lepillé, D., Kerbrat, P., Gomez, P., Paule, B., Genet, D., Hérait, P., Ecstein-Fraïssé, E., Joly, F.
Zdroj: In Annals of Oncology June 2007 18(6):1064-1070
Databáze: ScienceDirect